Competition between Intramolecular and Intermolecular Interactions in an Amyloid-Forming Protein

Journal of Molecular Biology

Volumn 389, Issue 4, 2009, Pages 776-786

  Routledge, Katy E ^a   Tartaglia, Gian Gaetano ^b   Platt, Geoffrey W ^a   Vendruscolo, Michele ^b   Radford, Sheena E ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

aggregation; amyloid; NMR relaxation; prediction; unfolded state

Indexed keywords

AMYLOID PROTEIN; BETA 2 MICROGLOBULIN; POLYPEPTIDE;

ACIDITY; ARTICLE; CHEMICAL REACTION KINETICS; FIBER; HUMAN; HYDROPHOBICITY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PH; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ASSEMBLY; PROTEIN CONFORMATION; PROTEIN DENATURATION; PROTEIN INTERACTION; PROTEIN STRUCTURE; QUANTITATIVE ANALYSIS; RNA TRANSLATION; SITE DIRECTED MUTAGENESIS;

EID: 65849165676     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2009.04.042     Document Type: Article

References (48)

1. Westermark P., Benson M.D., Buxbaum J.N., Cohen A.S., Frangione B., Ikeda S., et al. A primer of amyloid nomenclature. Amyloid 14 (2007) 179-183
2. Sunde M., and Blake C. The structure of amyloid fibrils by electron microscopy and X-ray diffraction. Adv. Protein Chem. 50 (1997) 123-159
3. Chiti F., and Dobson C.M. Protein misfolding, functional amyloid, and human disease. Annu. Rev. Biochem. 75 (2006) 333-366
4. Fowler D.M., Koulov A.V., Balch W.E., and Kelly J.W. Functional amyloid-from bacteria to humans. Trends Biochem. Sci. 32 (2007) 217-224
5. Cherny I., and Gazit E. Amyloids: not only pathological agents but also ordered nanomaterials. Angew. Chem., Int. Ed. Engl. 47 (2008) 4062-4069
6. Selkoe D.J. Folding proteins in fatal ways. Nature 426 (2003) 900-904
7. Sawaya M.R., Sambashivan S., Nelson R., Ivanova M.I., Sievers S.A., Apostol M.I., et al. Atomic structures of amyloid cross-β spines reveal varied steric zippers. Nature 447 (2007) 453-457
8. Wasmer C., Lange A., Van Melckebeke H., Siemer A.B., Riek R., and Meier B.H. Amyloid fibrils of the HET-s(218-289) prion form a β-solenoid with a triangular hydrophobic core. Science 319 (2008) 1523-1526
9. Margittai M., and Langen R. Fibrils with parallel in-register structure constitute a major class of amyloid fibrils: molecular insights from electron paramagnetic resonance spectroscopy. Q. Rev. Biophys. 41 (2008) 265-297
10. Tycko R. Molecular structure of amyloid fibrils: insights from solid-state NMR. Q. Rev. Biophys. 39 (2006) 1-55
11. Tartaglia G.G., Pawar A.P., Campioni S., Dobson C.M., Chiti F., and Vendruscolo M. Prediction of aggregation-prone regions in structured proteins. J. Mol. Biol. 380 (2008) 425-436
12. Sekijima Y., Kelly J.W., and Ikeda S. Pathogenesis of and therapeutic strategies to ameliorate the transthyretin amyloidoses. Curr. Pharm. Des. 14 (2008) 3219-3230
13. 2-microglobulin W60V mutant structure: implications for stability and amyloid aggregation. Biochem. Biophys. Res. Commun. 380 (2009) 543-547
14. Dumoulin M., Canet D., Last A.M., Pardon E., Archer D.B., Muyldermans S., et al. Reduced global cooperativity is a common feature underlying the amyloidogenicity of pathogenic lysozyme mutations. J. Mol. Biol. 346 (2005) 773-788
15. Guo Z., and Eisenberg D. The mechanism of the amyloidogenic conversion of T7 endonuclease I. J. Biol. Chem. 282 (2007) 14968-14974
16. Quintas A., Vaz D.C., Cardoso I., Saraiva M.J., and Brito R.M. Tetramer dissociation and monomer partial unfolding precedes protofibril formation in amyloidogenic transthyretin variants. J. Biol. Chem. 276 (2001) 27207-27213
17. Furukawa Y., Kaneko K., Yamanaka K., O'Halloran T.V., and Nukina N. Complete loss of post-translational modifications triggers fibrillar aggregation of SOD1 in the familial form of amyotrophic lateral sclerosis. J. Biol. Chem. 283 (2008) 24167-24176
18. Page L.J., Suk J.Y., Huff M.E., Lim H.J., Venable J., Yates J., et al. Metalloendoprotease cleavage triggers gelsolin amyloidogenesis. EMBO J. 24 (2005) 4124-4132
19. 2-microglobulin important for nucleation and elongation of aggregation. J. Mol. Biol. 378 (2008) 251-263
20. Xue W.F., Homans S.W., and Radford S.E. Systematic analysis of nucleation-dependent polymerization reveals new insights into the mechanism of amyloid self-assembly. Proc. Natl Acad. Sci. USA 105 (2008) 8926-8931
21. 2-microglobulin studied by NMR. J. Mol. Biol. 346 (2005) 279-294
22. 2-microglobulin-insights into the mechanism of fibril formation in vitro. J. Mol. Biol. 325 (2003) 249-257
23. 2-microglobulin-a role of the disulfide bond. Biochem. Biophys. Res. Commun. 304 (2003) 101-106
24. 2-microglobulin and insulin for amyloid-like segments. Proc. Natl Acad. Sci. USA 103 (2006) 4079-4082
25. Tartaglia G.G., and Vendruscolo M. The Zyggregator method for predicting protein aggregation propensities. Chem. Soc. Rev. 37 (2008) 1395-1401
26. Fernandez-Escamilla A.M., Rousseau F., Schymkowitz J., and Serrano L. Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins. Nat. Biotechnol. 22 (2004) 1302-1306
27. Conchillo-Sole O., de Groot N.S., Aviles F.X., Vendrell J., Daura X., and Ventura S. AGGRESCAN: a server for the prediction and evaluation of "hot spots" of aggregation in polypeptides. BMC Bioinformatics 8 (2007) 65
28. Uversky V.N. Amyloidogenesis of natively unfolded proteins. Curr. Alzheimer Res. 5 (2008) 260-287
29. 2-microglobulin by achromobacter protease I. J. Biol. Chem. 277 (2002) 1310-1315
30. 2-microglobulin in amyloid fibril formation. Biochemistry 42 (2003) 13536-13540
31. 2-microglobulin suggests a molecular model for the fibril. Proc. Natl Acad. Sci. USA 101 (2004) 10584-10589
32. Bjorkman P.J., Saper M.A., Samraoui B., Bennett W.S., Strominger J.L., and Wiley D.C. Structure of the human class I histocompatibility antigen, HLA-A2. Nature 329 (1987) 506-512
33. 2-microglobulin amyloid formation. J. Mol. Biol. 330 (2003) 943-954
34. Smith, D. P. & Radford, S. E. (2008). Hemodialysis related amyloidosis. In Protein Misfolding Diseases: Current and Emerging Principles and Possible Therapies (Ramirez-Alvarado, M., Kelly, J. & Dobson, C. M., eds). John Wiley & Sons, Inc., in press.
35. Sanchez de Groot N., Pallares I., Aviles F.X., Vendrell J., and Ventura S. Prediction of "hot spots" of aggregation in disease-linked polypeptides. BMC Struct. Biol. 5 (2005) 18
36. 2-microglobulin facilitates protein aggregation and fibril formation. Protein Sci. 9 (2000) 831-845
37. Vendruscolo M., Paci E., Dobson C.M., and Karplus M. Three key residues form a critical contact network in a protein folding transition state. Nature 409 (2001) 641-645
38. Chiti F., Stefani M., Taddei N., Ramponi G., and Dobson C.M. Rationalization of the effects of mutations on peptide and protein aggregation rates. Nature 424 (2003) 805-808
39. 2-microglobulin in amyloidosis in vitro. Protein Sci. 10 (2001) 1775-1784
40. 2-microglobulin studied by heteronuclear NMR. Protein Sci. 11 (2002) 2218-2229
41. Hamada D., Tanaka T., Tartaglia G.G., Pawar A.P., Vendruscolo M., Kawamura M., et al. Competition between folding, native-state dimerisation and amyloid aggregation in β-lactoglobulin. J. Mol. Biol. 386 (2009) 878-890
42. Wu K.P., Kim S., Fela D.A., and Baum J. Characterization of conformational and dynamic properties of natively unfolded human and mouse α-synuclein ensembles by NMR: implication for aggregation. J. Mol. Biol. 378 (2008) 1104-1115
43. Ehrnhoefer D.E., Bieschke J., Boeddrich A., Herbst M., Masino L., Lurz R., et al. EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers. Nat. Struct. Mol. Biol. 15 (2008) 558-566
44. Mishima T., Ohkuri T., Monji A., Imoto T., and Ueda T. A particular hydrophobic cluster in the residual structure of reduced lysozyme drastically affects the amyloid fibrils formation. Biochem. Biophys. Res. Commun. 356 (2007) 769-772
45. 2-microglobulin amyloid formation at neutral pH. Biochemistry 45 (2006) 2311-2321
46. Delaglio F., Grzesiek S., Vuister G.W., Zhu G., Pfeifer J., and Bax A. NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR 6 (1995) 277-293
47. Johnson B., and Blevins R. NMRView: a computer programme for the visualization and analysis of NMR data. J. Biomol. NMR 4 (1994) 603-614
48. 15N longitudinal decay and chemical exchange rates of systems in slow equilibrium. J. Biomol. NMR 4 (1994) 727-734